| Name | 2-Methoxy-6,7-dimethyl-9-propylimidazo[1,5-a]pyrido[3,2-e]pyrazin e |
|---|---|
| Synonyms | TC-E 5005 |
| Description | TC-E 5005 is a potent and selective PDE10A inhibitor with IC50 values of 7.28, 239, 779, 919, 3,100, and 3,700 nM for PDE10A, 2A, 11A, 5A, 7B and 3A, respectively. TC-E 5005 inhibits adrenergic and neurogenic smooth muscle contractions in the human prostate[1]. |
|---|---|
| Related Catalog | |
| Target |
PDE10A:7.28 nM (IC50) PDE2A:239 nM (IC50) hPDE11A:779 nM (IC50) PDE5A:919 nM (IC50) PDE7B:3100 nM (IC50) PDE3A:3700 nM (IC50) |
| In Vitro | TC-E 5005 (500 nM) inhibits norepinephrine or phenylephrine and EFS (electric field stimulation)-induced contraction of human prostate strips[1]. TC-E 5005 (500 nM) shows amplification of treprostinil-induced relaxations, which were significant from 0.03 to 30 μM treprostinil[1]. |
| References |
| Molecular Formula | C15H18N4O |
|---|---|
| Molecular Weight | 270.33000 |
| Exact Mass | 270.14800 |
| PSA | 52.31000 |
| LogP | 2.85540 |